BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17095401)

  • 1. Radioprotectants: adding quality of life to survivorship?
    Dest VM
    Semin Oncol Nurs; 2006 Nov; 22(4):249-56. PubMed ID: 17095401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncology nurses' attitudes, perceptions, and knowledge of quality-of-life assessment in patients with cancer.
    Lindley CM; Hirsch JD
    Oncol Nurs Forum; 1994; 21(1):103-8; discussion 108-10. PubMed ID: 8139993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in cancer survivorship: 20 years later.
    Meneses K; Benz R
    Semin Oncol Nurs; 2010 Feb; 26(1):36-46. PubMed ID: 20152577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
    Sarna L; Swann S; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Byhardt R; Wasserman T; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1378-84. PubMed ID: 18501528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amifostine and combined-modality therapeutic approaches.
    Mehta MP
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):95-101. PubMed ID: 10348267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amifostine and radiation therapy: past, present, and future.
    Tannehill SP; Mehta MP
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):69-77. PubMed ID: 8783671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amifostine in the management of radiation-induced and chemo-induced mucositis.
    Bensadoun RJ; Schubert MM; Lalla RV; Keefe D
    Support Care Cancer; 2006 Jun; 14(6):566-72. PubMed ID: 16586122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in how clinical nurses can evaluate and improve quality of life for individuals with cancer.
    King CR
    Oncol Nurs Forum; 2006 Jan; 33(1 Suppl):5-12. PubMed ID: 17202084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The state of the art in radiation therapy.
    Hogle WP
    Semin Oncol Nurs; 2006 Nov; 22(4):212-20. PubMed ID: 17095397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in quality of life at the end of life.
    Grant M; Sun V
    Semin Oncol Nurs; 2010 Feb; 26(1):26-35. PubMed ID: 20152576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing toxicities in pelvic malignancies.
    Friedland J
    J Support Oncol; 2004; 2(6 Suppl 3):19-23. PubMed ID: 15605921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in defining, conceptualizing, and measuring quality of life in pediatric patients with cancer.
    Hinds PS; Burghen EA; Haase JE; Phillips CR
    Oncol Nurs Forum; 2006 Jan; 33(1 Suppl):23-9. PubMed ID: 17202086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of the cytoprotectant amifostine.
    Lindemann K
    Clin J Oncol Nurs; 1998 Jul; 2(3):101-4. PubMed ID: 10232150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized phase II trial of amifostine for head and neck irradiation in lymphoma.
    Ng AK; Hickey G; Li S; Neuberg D; Mauch PM
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):20-4. PubMed ID: 15726518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential influence of cell protectors for dose escalation in cancer therapy: an analysis of amifostine.
    McCumber LM
    Med Dosim; 2004; 29(2):139-43. PubMed ID: 15191764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nursing management and radiation oncology.
    Farmer F
    Aust Nurs J; 1999 Jul; 7(1):suppl 1-3. PubMed ID: 10568916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oncology nursing to ensure quality care for cancer survivors: a report commissioned by the National Cancer Policy Board and Institute of Medicine.
    Ferrell BR; Virani R; Smith S; Juarez G;
    Oncol Nurs Forum; 2003; 30(1):E1-E11. PubMed ID: 12515992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of treatment intensification for head and neck cancer: concomitant chemoradiation randomised for radioprotection with amifostine.
    Braaksma M; van Agthoven M; Nijdam W; Uyl-de Groot C; Levendag P
    Eur J Cancer; 2005 Sep; 41(14):2102-11. PubMed ID: 16140526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced toxicities: the role of radioprotectants.
    Curran WJ
    Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):2-4. PubMed ID: 9794993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amifostine.
    Viele C
    Clin J Oncol Nurs; 1999 Jul; 3(3):128, 131. PubMed ID: 10690046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.